ICU Medical, Inc. (ICUI) Stock Analysis
A live, multi-source view of ICU Medical, Inc. (ICUI): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About ICU Medical, Inc.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options.
Sector: Healthcare · Industry: Medical Instruments & Supplies · United States · 13,000 employees · icumed.com
Key statistics · as of 2026-09-05
As of 2026-09-05, ICU Medical, Inc. (ICUI) had a market capitalization of $4.19B, a trailing P/E of 140.8 (forward 17.4) and a beta of 0.76; the shares traded in a 52-week range of $112.50 – $192.85 (28.3% over the year).
- Market cap
- $4.19B
- Enterprise value
- $5.18B
- Trailing P/E
- 140.8
- Forward P/E
- 17.4
- PEG ratio
- 0.08
- Price / book
- 1.95
- EPS (trailing)
- $1.19
- EPS (forward)
- $9.65
- Payout ratio
- 0.0%
- 52-week range
- $112.50 – $192.85
- 52-week change
- 28.3%
- Beta
- 0.76
- Average volume
- 299,136
- Shares outstanding
- 25.0M
- Short % of float
- 6.63%
- Profit margin
- 1.4%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-08
In RapidTradeView’s 2026-09-08 scan of the US universe, ICU Medical, Inc. (ICUI) last closed at $167.58 (the last completed close before that scan).
Technicals at the scan: RSI 41 (neutral territory), price -6.1% versus its 20-day average, 20-day versus 50-day average spread +6.8%, MACD histogram -2.68.
Sentiment inputs: StockTwits 60% bullish; analyst consensus score 81/100.
Next scheduled company event: in 58 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
RapidTradeView has recorded no Congress or insider filing for ICUI in the last 90 days. Coverage of House, Senate and SEC Form 4 filings began in July 2026, and insider sells are tracked for universe tickers only, so this is our record, not a guarantee that nothing was filed. Who is trading what
RapidTradeView pick record
ICUI has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls ICU Medical, Inc. (ICUI) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell ICUI.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.